Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2100 of 3546 entries
View as:

Complementary Testing to Evaluate Immunogenicity of Human Papillomavirus (HPV) Vaccine (580299) in Healthy Female Subjects Aged >/= 26 Years

Phase: N/A Priority: Normal
NCT ID: NCT00456807 Org: User:
Start: 04/30/07 End: 01/31/08 Due: 01/31/09

Study of GSK2132231A Antigen-Specific Cancer Immunotherapeutic in Patients With Inoperable Metastatic Cutaneous Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT00896480 Org: User:
Start: 05/19/09 End: 11/03/14 Due: 11/03/15

Study to Evaluate the Immunogenicity and Safety of a Second Vaccination With the Adjuvanted Influenza Vaccine Candidate

Phase: N/A Priority: Normal
NCT ID: NCT00385840 Org: User:
Start: 10/20/06 End: 02/05/07 Due: 02/05/08

Global Linerixibat Itch Study of Efficacy and Safety in Primary Biliary Cholangitis (PBC) (GLISTEN)

Phase: N/A Priority: Normal
NCT ID: NCT04950127 Org: User:
Start: 08/27/21 End: 12/20/24 Due: 12/20/25

Safety and Efficacy of Albiglutide in Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00849056 Org: User:
Start: 01/31/09 End: 01/31/13 Due: 01/31/14

Comparative Study of Umeclidinium/Vilanterol (UMEC/VI) in a Fixed Dose Combination With Indacaterol Plus Tiotropium

Phase: N/A Priority: Normal
NCT ID: NCT02257385 Org: User:
Start: 10/15/14 End: 05/04/15 Due: 05/04/16

Biodistribution of 89Zirconium-labelled GSK2398852 Using PET Imaging

Phase: N/A Priority: Normal
NCT ID: NCT03417830 Org: User:
Start: 04/06/18 End: 07/20/18 Due: 07/20/19

Study Of Treximet, Formerly Known as Trexima, In The Acute Treatment Of Multiple Migraine Attacks

Phase: N/A Priority: Normal
NCT ID: NCT00240617 Org: User:
Start: 10/31/05 End: 06/30/06 Due: 06/30/07

Safety Study To Assess Growth In Children With Seasonal Allergic And/Or Perennial Allergic Rhinitis Treated With GW685698X Aqueous Nasal Spray Or Placebo Nasal Spray

Phase: N/A Priority: Normal
NCT ID: NCT00109486 Org: User:
Start: 04/30/05 End: 11/30/05 Due: 11/30/06

A Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C -GSK1322322 After an Intravenous and an Oral Dose

Phase: N/A Priority: Normal
NCT ID: NCT01663389 Org: User:
Start: 08/10/12 End: 10/05/12 Due: 10/05/13

A Study to Examine the Effect of Particle Size on Bioequivalence and Bioavailability

Phase: N/A Priority: Normal
NCT ID: NCT00517543 Org: User:
Start: 08/31/07 End: 10/31/07 Due: 10/31/08

AVANDIA With Glyburide In African American And Hispanic Patients With Type 2 Diabetes Not Controlled by Glyburide Alone

Phase: N/A Priority: Normal
NCT ID: NCT00333723 Org: User:
Start: 07/28/00 End: 01/06/03 Due: 01/06/04

Phase II Study Evaluating Exemestane Alone Or In Combination With Pazopanib In Postmenopausal Women With Hormone Receptor Positive Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00615524 Org: User:
Start: 04/30/08 End: 11/30/12 Due: 11/30/13

Safety and Immunogenicity Study of GSK Biologicals' Seasonal Influenza Candidate Vaccine (GSK2321138A)

Phase: N/A Priority: Normal
NCT ID: NCT01204671 Org: User:
Start: 10/04/10 End: 06/06/11 Due: 06/06/12

An Intravenous (IV) Zanamivir Pharmacokinetics (PK) Study in Hospitalized Neonates and Infants With Influenza Infection

Phase: N/A Priority: Normal
NCT ID: NCT04494412 Org: User:
Start: 11/21/22 End: 04/30/26 Due: 04/30/27

Open Label Study of 908/RTV in Combination With Other PIs for the Treatment of Multi PI-Experienced HIV Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00144833 Org: User:
Start: 03/31/05 End: - Due: -

Efficacy, Safety, Reactogenicity & Immunogenicity of the Rotarix Vaccine in Japanese Infants

Phase: N/A Priority: Normal
NCT ID: NCT00480324 Org: User:
Start: 06/19/07 End: 11/21/09 Due: 11/21/10

Evaluation of Immunogenicity and Reactogenicity of Various Formulations of Recombinant Hepatitis B Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT00697970 Org: User:
Start: 11/30/93 End: 04/30/95 Due: 04/30/96

Study to Assess the Vaccine Efficacy Against Malaria Infection, in Children Immunized With the Primary and Yearly Booster of the RTS,S/AS01E Vaccine, as Part of Their Participation in the Malaria-094 (204889/NCT03276962) Study.

Phase: N/A Priority: Normal
NCT ID: NCT03281291 Org: User:
Start: 11/19/18 End: 10/23/23 Due: 10/23/24

Effects of the D3 Antagonist GSK598809 on Food Reward and Reinforcement

Phase: N/A Priority: Normal
NCT ID: NCT01039454 Org: User:
Start: 12/18/08 End: 04/26/10 Due: 04/26/11

First Time in Human Study of Intravenous Interleukin-18 Antibody

Phase: N/A Priority: Normal
NCT ID: NCT01035645 Org: User:
Start: 01/05/10 End: 07/11/12 Due: 07/11/13

Study to Evaluate Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A When Co-administered With Pneumovax 23™ in Adults Aged 50 Years and Older

Phase: N/A Priority: Normal
NCT ID: NCT02045836 Org: User:
Start: 03/05/14 End: 06/17/16 Due: 06/17/17

Number of Rotavirus (RV) Related Hospitalizations in Belgium - Season 2010-2011

Phase: N/A Priority: Normal
NCT ID: NCT01563159 Org: User:
Start: 03/31/15 End: 12/31/17 Due: 12/31/18

Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine

Phase: N/A Priority: Normal
NCT ID: NCT00435461 Org: User:
Start: 12/20/06 End: 02/28/07 Due: 02/28/08

Mepolizumab as Add-on Treatment IN Participants With COPD Characterized by Frequent Exacerbations and Eosinophil Level

Phase: N/A Priority: Normal
NCT ID: NCT04133909 Org: User:
Start: 10/30/19 End: 08/08/24 Due: 08/08/25